Valneva SE AYJ
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis; DUKORAL®,…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryFrance
Employees700
TickerAYJ
Statistics
Market Cap$461.8M
Revenue (TTM)$165.1M
Net Income—
Net Margin—
EPS—
P/E70.98
P/S2.80
P/B5.36
EV/EBITDA-6.29
ROE-109.6%
Dividend Yield—
Price$2.66
Data: Twelve Data · Revenue = mcap / P/S